XML 143 R125.htm IDEA: XBRL DOCUMENT v3.22.2.2
Share-Based Compensation - Additional Information (Detail)
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2022
CAD ($)
Jun. 30, 2021
CAD ($)
Jun. 30, 2022
CAD ($)
shares
Jun. 30, 2021
CAD ($)
Dec. 31, 2021
CAD ($)
shares
Dec. 31, 2021
CAD ($)
$ / shares
Dec. 31, 2020
CAD ($)
shares
Dec. 31, 2020
CAD ($)
$ / shares
Dec. 31, 2019
CAD ($)
Disclosure of terms and conditions of share-based payment arrangement [line items]                  
Share based compensation by share based award number of options granted during the period | shares         654,847   839,478    
Share based compensation by share based award weighted average fair value of stock options granted during the period | $ / shares           $ 2.89   $ 2.15  
Allocated share based compensation $ (2,667,000) $ 3,158,000 $ 1,382,000 $ 8,425,000 $ 12,937,000   $ 1,816,000   $ 7,749,000
Number of trading days for determining the weighted average share price             5 days    
Share based compensation by share based award vesting term             3 years    
Share based compensation by share based award weighted average fair value of equity instruments other than options granted | $ / shares           $ 7.85   $ 5.51  
Current Liabilities [Member]                  
Disclosure of terms and conditions of share-based payment arrangement [line items]                  
Reserve of share-based payments 8,700,000   8,700,000   4,300,000 $ 4,300,000      
Other longterm liabilities [Member]                  
Disclosure of terms and conditions of share-based payment arrangement [line items]                  
Reserve of share-based payments $ 9,500,000   $ 9,500,000   13,400,000 13,400,000      
Top of range [member]                  
Disclosure of terms and conditions of share-based payment arrangement [line items]                  
Share Based Compensation Employer Contribution         3,000        
Deferred Share Units [Member]                  
Disclosure of terms and conditions of share-based payment arrangement [line items]                  
Allocated share based compensation         $ 3,053,000   $ (1,830,000)   (720,000)
Number of trading days for determining the weighted average share price         5 days        
Share based compensation by share based award equity instruments other than options granted | shares     146,942   247,317        
Deferred Share Units [Member] | Director And Executive [Member]                  
Disclosure of terms and conditions of share-based payment arrangement [line items]                  
Allocated share based compensation         $ 2,100,000   2,600,000    
Phantom Share Entitlement Plan [Member]                  
Disclosure of terms and conditions of share-based payment arrangement [line items]                  
Allocated share based compensation         $ 102,000   $ (54,000)   (449,000)
Share based compensation by share based award equity instruments other than options granted | shares         24,715   34,853    
Intrinsic value of liabilities from share based payment transactions         $ 900,000 900,000 $ 0 $ 0  
Phantom Share Entitlement Plan [Member] | Current Liabilities [Member]                  
Disclosure of terms and conditions of share-based payment arrangement [line items]                  
Liabilities from share based transaction         200,000 200,000 100,000 100,000  
Performance Share Units [Member]                  
Disclosure of terms and conditions of share-based payment arrangement [line items]                  
Allocated share based compensation         $ 3,470,000   $ 667,000   2,754,000
Number of trading days for determining the weighted average share price         5 days        
Share based compensation by share based award equity instruments other than options granted | shares         419,195        
Share based compensation number of days within which award will be settled from the date of determination of vesting percentage             14 days    
Settlement of liability in respect of share based transactions         $ 1,000,000   $ 500,000    
Performance Share Units [Member] | Current Liabilities [Member]                  
Disclosure of terms and conditions of share-based payment arrangement [line items]                  
Liabilities from share based transaction         2,000,000 2,000,000 $ 600,000 600,000  
Performance Share Units [Member] | Bottom of range [member]                  
Disclosure of terms and conditions of share-based payment arrangement [line items]                  
Share based compensation by share based award vesting percentage             0.00%    
Performance Share Units [Member] | Top of range [member]                  
Disclosure of terms and conditions of share-based payment arrangement [line items]                  
Share based compensation by share based award vesting percentage             200.00%    
Restricted Share Units [Member]                  
Disclosure of terms and conditions of share-based payment arrangement [line items]                  
Allocated share based compensation         $ 2,751,000   $ 755,000   $ 2,199,000
Number of trading days for determining the weighted average share price         5 days        
Share based compensation by share based award equity instruments other than options granted | shares         472,819        
Restricted Share Units [Member] | Current Liabilities [Member]                  
Disclosure of terms and conditions of share-based payment arrangement [line items]                  
Liabilities from share based transaction         $ 1,300,000 1,300,000 $ 900,000 900,000  
Restricted Share Units [Member] | Directors And Certain Key Executives [Member]                  
Disclosure of terms and conditions of share-based payment arrangement [line items]                  
Share based compensation by share based award equity instruments other than options granted | shares         472,819   680,200    
Share based compensation number of days within which award will be settled from the date of determination of vesting percentage             30 days    
Settlement of liability in respect of share based transactions         $ 2,300,000   $ 800,000    
Cash Performance Target Plan [Member]                  
Disclosure of terms and conditions of share-based payment arrangement [line items]                  
Share based compensation by share based award term of expiry         3 years        
Share based compensation number of days within which award will be settled from the date of determination of vesting percentage             30 days    
Settlement of liability in respect of share based transactions         $ 1,500,000   $ 500,000    
Share based compensation by share based equity instruments other than options granted during the period value         2,200,000   2,400,000    
Cash Performance Target Plan [Member] | Current Liabilities [Member]                  
Disclosure of terms and conditions of share-based payment arrangement [line items]                  
Liabilities from share based transaction         $ 800,000 $ 800,000 $ 500,000 $ 500,000  
Cash Performance Target Plan [Member] | Tranche One [Member]                  
Disclosure of terms and conditions of share-based payment arrangement [line items]                  
Share based compensation by share based award vesting percentage         0.33%        
Cash Performance Target Plan [Member] | Tranche Two [Member]                  
Disclosure of terms and conditions of share-based payment arrangement [line items]                  
Share based compensation by share based award vesting percentage         0.03%        
Cash Performance Target Plan [Member] | Tranche Three [Member]                  
Disclosure of terms and conditions of share-based payment arrangement [line items]                  
Share based compensation by share based award vesting percentage         0.03%        
Employee Share Purchase Plan [Member] | Bottom of range [member]                  
Disclosure of terms and conditions of share-based payment arrangement [line items]                  
Share Based Compensation Employer Contribution         $ 1,000